Evidence map›Paper›PMID 20463816›Full record

ArticlePLoS pathogens2010

Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.

Lance D Eckerle, Michelle M Becker, Rebecca A Halpin, Kelvin Li, Eli Venter, Xiaotao Lu, Sana Scherbakova, Rachel L Graham, Ralph S Baric, Timothy B Stockwell and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 299 papers.

0numbers the graph read from it
0cells of the map it votes in
299citing papers in PubMed
25.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

299 citing papers in PubMed, 516 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

239 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lance D EckerleDepartment of Pediatrics and Microbiology and Immunology and Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Michelle M Becker
Rebecca A Halpin
Kelvin Li
Eli Venter
Xiaotao Lu
Sana Scherbakova
Rachel L Graham
Ralph S Baric
Timothy B Stockwell
David J Spiro
Mark R Denison
J. Craig Venter Institute · USVanderbilt University Medical Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Yessinia autotransporters (Yaps): Structure, function, and host responseU54AI057157 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CROWE, JAMES E · 2003 to 2013
$91.4M
SARS Replicase Proteins in Pathogenesis and ReplicationP01AI059443 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSTON, ROBERT E. · 2005 to 2009
$9.2M
POLYMERASE PROTEINS IN CORONAVIRUS REPLICATIONR01AI026603 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENISON, MARK R · 1994 to 2014
$4.1M
Cellular &Molecular Microbiology Postgraduate TrainingT32AI049824 · NIAID · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2001 to 2005
$1.1M
SARS-CoV Transcription Network Remodeling and the Attenuation of PathogenesisF32AI080148 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GRAHAM, RACHEL LAUREN · 2008 to 2010
$155k
NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NIAID NIH HHS F32 AI080148NIAID NIH HHS F32-AI080148NIAID NIH HHS HHSN272200900007CNIAID NIH HHS N01 AI030071NIAID NIH HHS P01 AI059443NIAID NIH HHS P01-AI059443NIAID NIH HHS R01 AI026603NIAID NIH HHS R01-AI026603NIAID NIH HHS T32 AI049824NIAID NIH HHS T32-AI049824NIAID NIH HHS U54 AI057157NIAID NIH HHS U54-AI057157
6 · The paper itself

Abstract

Most RNA viruses lack the mechanisms to recognize and correct mutations that arise during genome replication, resulting in quasispecies diversity that is required for pathogenesis and adaptation. However, it is not known how viruses encoding large viral RNA genomes such as the Coronaviridae (26 to 32 kb) balance the requirements for genome stability and quasispecies diversity. Further, the limits of replication infidelity during replication of large RNA genomes and how decreased fidelity impacts virus fitness over time are not known. Our previous work demonstrated that genetic inactivation of the coronavirus exoribonuclease (ExoN) in nonstructural protein 14 (nsp14) of murine hepatitis virus results in a 15-fold decrease in replication fidelity. However, it is not known whether nsp14-ExoN is required for replication fidelity of all coronaviruses, nor the impact of decreased fidelity on genome diversity and fitness during replication and passage. We report here the engineering and recovery of nsp14-ExoN mutant viruses of severe acute respiratory syndrome coronavirus (SARS-CoV) that have stable growth defects and demonstrate a 21-fold increase in mutation frequency during replication in culture. Analysis of complete genome sequences from SARS-ExoN mutant viral clones revealed unique mutation sets in every genome examined from the same round of replication and a total of 100 unique mutations across the genome. Using novel bioinformatic tools and deep sequencing across the full-length genome following 10 population passages in vitro, we demonstrate retention of ExoN mutations and continued increased diversity and mutational load compared to wild-type SARS-CoV. The results define a novel genetic and bioinformatics model for introduction and identification of multi-allelic mutations in replication competent viruses that will be powerful tools for testing the effects of decreased fidelity and increased quasispecies diversity on viral replication, pathogenesis, and evolution.

Indexed as

Genome, ViralSevere acute respiratory syndrome-related coronavirusAmino Acid SequenceAnimalsChlorocebus aethiopsEvolution, MolecularExoribonucleasesGenetic EngineeringGenetic VariationModels, GeneticMolecular Sequence DataMutationPhenotypePolymorphism, Single NucleotideSevere Acute Respiratory SyndromeVero CellsExoribonucleasesnsp14 protein, SARS coronavirusViral Nonstructural Proteins

Identifiers

PMID20463816
PMCPMC2865531
OpenAlexW2018212701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.